{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:59:27Z","timestamp":1790164767786,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.leukres.2021.106653","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:07:07Z","timestamp":1624925227000},"page":"106653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["MicroRNA-211 attenuates cell proliferation in T-cell lymphoblastic lymphoma through targeting TCF12"],"prefix":"10.1016","volume":"110","author":[{"given":"Licai","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106653_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2021.106653_bib0010","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1182\/bloodadvances.2020001822","article-title":"T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?","volume":"4","author":"Kroeze","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2021.106653_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.12722","article-title":"Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment","volume":"96","author":"Bassan","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2021.106653_bib0020","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","article-title":"Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group","volume":"27","author":"Burkhardt","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2021.106653_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","article-title":"MiRNA biogenesis and regulation of diseases: an overview","volume":"1509","author":"Vishnoi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.leukres.2021.106653_bib0030","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.leukres.2021.106653_bib0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsmb.2296","article-title":"The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC","volume":"19","author":"Fabian","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.leukres.2021.106653_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.leukres.2021.106653_bib0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41388-020-01581-9","article-title":"MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK","volume":"40","author":"Na","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2021.106653_bib0050","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1038\/s41388-020-01422-9","article-title":"MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2021.106653_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2018.09.009","article-title":"Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line","volume":"74","author":"Podshivalova","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2021.106653_bib0060","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106653_bib0065","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.01.031","article-title":"Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing","volume":"152","author":"Auyeung","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2021.106653_bib0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.leukres.2021.106653_bib0075","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2021.106653_bib0080","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.leukres.2021.106653_bib0085","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2014.08.005","article-title":"Emerging roles of RNA modification: m(6)A and U-tail","volume":"158","author":"Lee","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2021.106653_bib0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbagrm.2018.12.002","article-title":"m6A modification of non-coding RNA and the control of mammalian gene expression","volume":"1862","author":"Coker","year":"2019","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.leukres.2021.106653_bib0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/2211536606666170511102219","article-title":"m6A Modification and Implications for microRNAs","volume":"6","author":"Erson-Bensan","year":"2017","journal-title":"Microrna"},{"key":"10.1016\/j.leukres.2021.106653_bib0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.leukres.2021.106653_bib0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N(6)-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.leukres.2021.106653_bib0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarcon","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2021.106653_bib0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymthe.2019.11.016","article-title":"METTL14 suppresses CRC progression via regulating N6-methyladenosine-dependent primary miR-375 processing","volume":"28","author":"Chen","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.leukres.2021.106653_bib0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12967-020-02494-7","article-title":"Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in hepatocellular carcinoma","volume":"18","author":"Qin","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.leukres.2021.106653_bib0125","doi-asserted-by":"crossref","first-page":"e3270","DOI":"10.1002\/jgm.3270","article-title":"miR-211-5p is down-regulated and a prognostic marker in bladder cancer","volume":"22","author":"Wang","year":"2020","journal-title":"J. Gene Med."},{"key":"10.1016\/j.leukres.2021.106653_bib0130","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41419-018-0793-5","article-title":"LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin\/Fak\/Src signaling","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2021.106653_bib0135","first-page":"14013","article-title":"MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.leukres.2021.106653_bib0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2016.12.020","article-title":"MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4","volume":"485","author":"Xu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2021.106653_bib0145","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/0008-5472.CAN-17-1318","article-title":"miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma","volume":"78","author":"Diaz-Martinez","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2021.106653_bib0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41556-017-0006-y","article-title":"A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival","volume":"20","author":"Bu","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.leukres.2021.106653_bib0155","article-title":"microRNA-211 promotes invasion and migration of colorectal cancer cells by targeting FABP4 via PPARgamma","author":"Zhao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.leukres.2021.106653_bib0160","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.7150\/thno.34973","article-title":"TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression","volume":"9","author":"Yang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.leukres.2021.106653_bib0165","doi-asserted-by":"crossref","first-page":"152527","DOI":"10.1016\/j.prp.2019.152527","article-title":"TCF12 overexpression as a poor prognostic factor in ovarian cancer","volume":"215","author":"Gao","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.leukres.2021.106653_bib0170","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1074\/jbc.M111.258947","article-title":"TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2021.106653_bib0175","doi-asserted-by":"crossref","first-page":"13903","DOI":"10.1002\/jcb.28664","article-title":"High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K\/AKT pathway","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:33Z","timestamp":1758934893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"alternative-id":["S0145212621001545"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106653","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-211 attenuates cell proliferation in T-cell lymphoblastic lymphoma through targeting TCF12","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106653"}}